Advertisement
Clinical Trials: Immunotherapy

Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study

John W. Moroney, John Powderly, Christopher H. Lieu, Johanna C. Bendell, S. Gail Eckhardt, Ching-Wei Chang, Luciana Molinero, Jessica Spahn, Patrick Williams, Yvonne G. Lin and F. Stephen Hodi
DOI: 10.1158/1078-0432.CCR-20-0477 Published November 2020

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top
View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study
John W. Moroney, John Powderly, Christopher H. Lieu, Johanna C. Bendell, S. Gail Eckhardt, Ching-Wei Chang, Luciana Molinero, Jessica Spahn, Patrick Williams, Yvonne G. Lin and F. Stephen Hodi
Clin Cancer Res November 1 2020 (26) (21) 5631-5637; DOI: 10.1158/1078-0432.CCR-20-0477
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement